Fundz
Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →

Conexeu Sciences announced it raised $62,700 in an initial filing from an offering of $62,700

PUBLIC · CNXUJul 31, 20269 days ago

Amount Raised

$62,700

Round Type

Pre-Seed

RenoBiotechnology

Company Information

Company

Conexeu Sciences

Location

Reno, Nevada, United States

About

Conexeu Sciences is a biotechnology company advancing regenerative medicine with its patented collagen flowable gel platform. Emerging from over a decade of University research, Conexeu is developing this groundbreaking technology that could transform wound care, medical aesthetics, and tissue engineering. The company holds patents in the U.S., E.U., Japan, Australia, and pending in Canada, underscoring its global leadership in this innovation.

Related People

Suggested for you
1 contact
Verified contactsDavid B., Director, Founder hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for Conexeu Sciences's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.